Online tool can predict breast cancer relapse after hormone therapy

29 Aug 2018


The new online tool ‘CTS5’ can be used to determine if a patient is at risk of their breast cancer returning following hormone therapy, according to research published in the Journal of Clinical Oncology.

MedicalXpress


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story